期刊文献+

人突变CD59基因表达蛋白功能的研究 被引量:4

A STUDY ON THE FUNCTION OF MUTANT HUMAN CD59 GENE EXPRESSION PROTEIN
下载PDF
导出
摘要 ①目的构建8种突变CD59基因真核表达系统,观测突变的人CD59基因在中国仓鼠卵巢(CHO)细胞中的表达及抗补体活性。②方法以荧光活化细胞分类法、免疫荧光法及免疫印迹法检测突变CD59基因转染CHO细胞表达的情况,染料释放实验检测正常突变的CD59分子糖基化前后的抗补体活性。③结果转入突变CD59基因组荧光阳性细胞百分率明显高于对照组,染料释放率低于对照组。④结论CD59突变基因可在CHO细胞表面得到有效表达,该CD59分子具有抗补体活性,但在高糖环境下易被糖基化失活而失去抗补体活性。 Objective To construct eight kinds of mutant CD59 gene expression cell lines and to study the expression and anti complement function of the gene molecules in CHO cell. Methods FACS, FITC and Western-blot were used to confirm transfection and expression of mutant CD59 gene in CHO cells. Dye Release Assay was used to detect the anti-complement function of normal and mutant CD59 molecules before and after glycosylation. Results The fluorescence positive cell rate was significantly higher in the CHO group which had been transfected with mutant CD59 gene than in the control group. The dye release rate was lower than control group. Conclusion Mutant human CD59 genes obtain effectively expression in CHO cell surface. The mutant CD59 molecule bear the anti-complement function, but are easy to lose by glycation in the environment containing high concentration of glucose.
出处 《青岛大学医学院学报》 CAS 2005年第3期220-222,225,共4页 Acta Academiae Medicinae Qingdao Universitatis
基金 国家自然科学基金资助项目(批准号:30170893)
关键词 基因 CD59 基因突变 基因表达 gene, CD59 genemutant gene expression
  • 相关文献

参考文献7

  • 1Bodian DL, Davis SJ, Morgan BP, et al. Mutational analysis of the active site and antibody epitopes of the complement inhibitory glycoprotein, CD59 [J]. J Exp Med,1997,185:507.
  • 2Halperin JA, Taratuska A, Rynkiewicz MA, et al. Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex(C5b-9)[J]. Blood,1993,81 :200.
  • 3Brooimans RA. Relative roles of decay-accelerating factor, membrane cofactor prtotein, and CD59 in the protection of human endothelial cells against complement mediated lysis[J]. Eur J Immun,1992,22:3135.
  • 4金冬雁译. 分子克隆实验指南[M]. 第2版.北京:科学出版社,1995.870.
  • 5Ferriani VP. C5b-9 binds to N-termianl portion of CD59 [J]. Mol Immunol, 1993, 30(Suppl1):10.
  • 6Sims PJ, Faioni EM, Wiedmer T, et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity[J]. J Biol Chem, 1988,263:18205.
  • 7Acossta J, Halperin JA. Inhibition of the complement regulatory protein CD59 by non-enzymatic glycation:its potential pathogenic role in the proliferative complications of diabetes mellitus[J]. J Investig Med, 1996b,44:199A.

同被引文献35

  • 1杜瑞琴,白云.CD59的结构与功能关系研究进展[J].免疫学杂志,2000,16(z1):18-23. 被引量:6
  • 2陈政良,谢佩蓉,郑萍.Clq调理酵母多糖颗粒刺激U937细胞产生TNF-α[J].免疫学杂志,1996,12(1):9-13. 被引量:2
  • 3秦诚,蔡小勇.补体调节蛋白CD46、CD55及CD59在肿瘤免疫治疗中的研究进展[J].癌症,2006,25(11):1450-1453. 被引量:19
  • 4MARK J S,DALE I G,JOSEPH A T.A fresh look at tumor immunosurveillance and immunotherapy[J].Nature Immunology,2001,9(4):293-299.
  • 5GAVIN P D,LIOYD J O,ROBERT D S.The immunobiology of cancer immunosurveillance and immunoediting[J].Immunity,2004,21:137-148.
  • 6FISHEISON Z,DONIN N,ZELL S,et al.Obstacles to cancer immunotherapy:expression of membrane complement regulatory proteins (mCRPs) in tumors[J].Mol Immunol,2003,40(2/4):109-123.
  • 7DE N C,FONSATTI E,SIGALOTTI L,et al.Recombinant transmembrane CD59 (CD59-TM) confers complement resis-tance to GPI-anchored protein defective melanoma cells[J].J Cell Physiol,2002,190(2):200-206.
  • 8金冬雁译.分子克隆实验指南[M].第2版.北京:科学出版社,1995:5-57,870-898.
  • 9BABIKER A A,NILSSON B,RONQUIST G,et al.Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack[J].Prostate,2005,62(2):105-114.
  • 10AZZAZY H M,HIGHSMITH W E.Phage display technology:clinical applications and recent innovations[J].Clin Biochem,2002,35(6):425-445.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部